Long-Term Use of Rosuvastatin: A Critical Risk Benefit Appraisal and Comparison With Other Antihyperlipidemics

Drug, Healthcare and Patient Safety - New Zealand
doi 10.2147/dhps.s4928
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Short-Term and Long-Term Hearing Aid Benefit and User Satisfaction: A Comparison Between Two Fitting Protocols

Journal of the American Academy of Audiology
SpeechHearing
2007English

What Is the Risk-Benefit Ratio of Long-Term Antipsychotic Treatment in People With Schizophrenia?

World Psychiatry
PsychiatryMental HealthPsychiatric Mental Health
2018English

Long-Term Analgesic Use After Low-Risk Surgery

Archives of Internal Medicine
2012English

Use of Corticosteroids for the Treatment of Respiratory and Other Disorders: Estimating Benefit to Risk Relationship

Lungs and Breathing
2018English

Long-Term Central Venous Catheter Use and Risk of Infection in Older Adults With Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Long-Term Statin Use in Patients With Lung Cancer and Dyslipidemia Reduces the Risk of Death

Oncotarget
Oncology
2016English

Reliability Differentiation and Uniform Risk in Standards: A Critical Review and a Practical Appraisal

2019English

Long-Term Outcomes of Status Epilepticus: A Critical Assessment

Epilepsia
Neurology
2018English

A Critical Appraisal of WinEcon and Its Use in a First-Year Undergraduate Economics Programme

Research in Learning Technology
Computer Science ApplicationsEducation
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy